| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Departments of Surgery II [E. T., K. H., A. N.] and Laboratory Medicine [T. N.], Nagoya University School of Medicine, Nagoya 466-8550, Japan
The expression of PGP9.5 was evaluated using immunohistochemistry in 69 resected ductal carcinomas of the pancreas and in normal pancreatic tissue. Overexpression did not seem to differ with histological type or pathological stage. A significant negative correlation was found between overexpression of PGP9.5 and postoperative survival. Multivariate analysis also suggested PGP9.5 along with tumor stage and extrapancreatic plexus invasion as strong predictors of the outcome. This study suggests that PGP9.5 expression may be used as a marker for predicting the outcome of resection-treated pancreatic cancer patients.
This article has been cited by other articles:
|
|
 |
|
  V. M. Howell, A. Gill, A. Clarkson, A. E. Nelson, R. Dunne, L. W. Delbridge, B. G. Robinson, B. T. Teh, O. Gimm, and D. J. Marsh Accuracy of Combined Protein Gene Product 9.5 and Parafibromin Markers for Immunohistochemical Diagnosis of Parathyroid Carcinoma J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 434 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Madoz-Gurpide, R. Kuick, H. Wang, D. E. Misek, and S. M. Hanash Integral Protein Microarrays for the Identification of Lung Cancer Antigens in Sera That Induce a Humoral Immune Response Mol. Cell. Proteomics, February 1, 2008; 7(2): 268 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Ramos-Vara and M. A. Miller Immunohistochemical Detection of Protein Gene Product 9.5 (PGP 9.5) in Canine Epitheliotropic T-Cell Lymphoma (Mycosis Fungoides) Vet. Pathol., January 1, 2007; 44(1): 74 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Seliger, A. Fedorushchenko, W. Brenner, A. Ackermann, D. Atkins, S. Hanash, and R. Lichtenfels Ubiquitin COOH-Terminal Hydrolase 1: A Biomarker of Renal Cell Carcinoma Associated with Enhanced Tumor Cell Proliferation and Migration[?Q1: Running head: UCHL1, a Biomarker of RCC. Short title OK?Q1] Clin. Cancer Res., January 1, 2007; 13(1): 27 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Carolan, A. Heguy, B.-G. Harvey, P. L. Leopold, B. Ferris, and R. G. Crystal Up-regulation of Expression of the Ubiquitin Carboxyl-Terminal Hydrolase L1 Gene in Human Airway Epithelium of Cigarette Smokers. Cancer Res., November 15, 2006; 66(22): 10729 - 10740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. McCampbell, D. Truong, D. C. Broom, A. Allchorne, K. Gable, R. G. Cutler, M. P. Mattson, C. J. Woolf, M. P. Frosch, J. M. Harmon, et al. Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in vivo and confers an age-dependent neuropathy Hum. Mol. Genet., November 15, 2005; 14(22): 3507 - 3521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Mandelker, K. Yamashita, Y. Tokumaru, K. Mimori, D. L. Howard, Y. Tanaka, A. L. Carvalho, W.-W. Jiang, H. L. Park, M. S. Kim, et al. PGP9.5 Promoter Methylation Is an Independent Prognostic Factor for Esophageal Squamous Cell Carcinoma Cancer Res., June 1, 2005; 65(11): 4963 - 4968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-P. Sher, J.-Y. Shih, P.-C. Yang, S. R. Roffler, Y.-W. Chu, C.-W. Wu, C.-L. Yu, and K. Peck Prognosis of Non-Small Cell Lung Cancer Patients by Detecting Circulating Cancer Cells in the Peripheral Blood with Multiple Marker Genes Clin. Cancer Res., January 1, 2005; 11(1): 173 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Skvortsov, B. Sarg, J. Loeffler-Ragg, I. Skvortsova, H. Lindner, H. Werner Ott, P. Lukas, K. Illmensee, and H. Zwierzina Different proteome pattern of epidermal growth factor receptor-positive colorectal cancer cell lines that are responsive and nonresponsive to C225 antibody treatment Mol. Cancer Ther., December 1, 2004; 3(12): 1551 - 1558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ovaa, B. M. Kessler, U. Rolen, P. J. Galardy, H. L. Ploegh, and M. G. Masucci Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells PNAS, February 24, 2004; 101(8): 2253 - 2258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G J Ebenezer and E Daniel Expression of protein gene product 9.5 in lepromatous eyes showing ciliary body nerve damage and a "dying back" phenomenon in the posterior ciliary nerves Br. J. Ophthalmol., February 1, 2004; 88(2): 178 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yamazaki, K. Hibi, T. Takase, E. Tezel, H. Nakayama, Y. Kasai, K. Ito, S. Akiyama, T. Nagasaka, and A. Nakao PGP9.5 as a Marker for Invasive Colorectal Cancer Clin. Cancer Res., January 1, 2002; 8(1): 192 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Brichory, D. Beer, F. LeNaour, T. Giordano, and S. Hanash Proteomics-based Identification of Protein Gene Product 9.5 as a Tumor Antigen That Induces a Humoral Immune Response in Lung Cancer Cancer Res., November 1, 2001; 61(21): 7908 - 7912. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
